ENTITY
Zylox-Tonbridge Medical Technology

Zylox-Tonbridge Medical Technology (2190 HK)

42
Analysis
Health CareChina
Leading player in the neuro- and peripheral-vascular interventional medical device market in China.
more
Refresh
21 May 2023 09:29

China Healthcare Weekly (May.19) - "Hedge Logic" Of CXO, Beijing's DRG+VBP Policy, Zylox-Tonbridge

Beijing issued new VBP+DRG policy for sports medicine/neurointervention/electrophysiology. CXO's "hedge logic" doesn't guarantee the whole industry...

Logo
305 Views
Share
15 May 2023 08:55

Acotec Scientific (6669.HK) - What Value Boston Scientific Will Bring Is Crucial to Future Valuation

There're many highlights in Acotec’s performance last year,but growth ceiling is obvious if rely solely on China market.Boston Scientific's...

Logo
303 Views
Share
26 Jan 2023 22:50

Acotec (6669 HK): Boston Scientific’s HK$20 Partial Offer Unconditional

Based on the current proration of 82.71% and at the last close price of HK$19.78 per share, the breakeven price is HK$19.00 per share.

Logo
405 Views
Share
03 Jan 2023 16:47

Acotec (6669 HK): Boston Scientific’s HK$20 Partial Offer Now Open

Irrevocables ensure that it will be declared unconditional on or before the first closing date. Based on a minimum proration of 71.31% and at the...

Logo
519 Views
Share
11 Dec 2022 09:10

Acotec Scientific Holdings (6669.HK) - A Game Changer with Solid Long-Term Logic

Acotec is able to break the monopoly position of foreign products in China and has entered the harvest season. As the first China company...

Logo
442 Views
Share
x